BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1015 related articles for article (PubMed ID: 9221830)

  • 1. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
    Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.
    Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
    Ramamoorthy K; Vyhlidal C; Wang F; Chen I; Safe S; McDonnell DP; Leonard LS; Gaido KW
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):93-100. PubMed ID: 9356311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxylated polychlorinated biphenyl metabolites are anti-estrogenic in a stably transfected human breast adenocarcinoma (MCF7) cell line.
    Kramer VJ; Helferich WG; Bergman A; Klasson-Wehler E; Giesy JP
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):363-76. PubMed ID: 9194421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro.
    Connor K; Howell J; Chen I; Liu H; Berhane K; Sciarretta C; Safe S; Zacharewski T
    Fundam Appl Toxicol; 1996 Mar; 30(1):93-101. PubMed ID: 8812239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro estrogenicity of the catechol metabolites of selected polychlorinated biphenyls.
    Garner CE; Jefferson WN; Burka LT; Matthews HB; Newbold RR
    Toxicol Appl Pharmacol; 1999 Jan; 154(2):188-97. PubMed ID: 9925803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155).
    Fielden MR; Chen I; Chittim B; Safe SH; Zacharewski TR
    Environ Health Perspect; 1997 Nov; 105(11):1238-48. PubMed ID: 9370515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone-like and estrogenic activity of hydroxylated PCBs in cell culture.
    Kitamura S; Jinno N; Suzuki T; Sugihara K; Ohta S; Kuroki H; Fujimoto N
    Toxicology; 2005 Mar; 208(3):377-87. PubMed ID: 15695023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,2',6,6'-Tetrachlorobiphenyl is estrogenic in vitro and in vivo.
    Arcaro KF; Yi L; Seegal RF; Vakharia DD; Yang Y; Spink DC; Brosch K; Gierthy JF
    J Cell Biochem; 1999 Jan; 72(1):94-102. PubMed ID: 10025670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies.
    Dickerson R; Keller LH; Safe S
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):287-98. PubMed ID: 8545839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS; Parker CJ; McCague R; Jordan VC
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
    Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
    Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ah receptor and estrogen receptor-dependent modulation of gene expression by extracts of diesel exhaust particles.
    Meek MD
    Environ Res; 1998 Nov; 79(2):114-21. PubMed ID: 9841810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for the interaction of 91 hydroxylated polychlorinated biphenyls with estrogen and thyroid hormone receptors.
    Arulmozhiraja S; Shiraishi F; Okumura T; Iida M; Takigami H; Edmonds JS; Morita M
    Toxicol Sci; 2005 Mar; 84(1):49-62. PubMed ID: 15601674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters.
    Zacharewski TR; Meek MD; Clemons JH; Wu ZF; Fielden MR; Matthews JB
    Toxicol Sci; 1998 Dec; 46(2):282-93. PubMed ID: 10048131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased [3H]phorbol ester binding in rat cerebellar granule cells and inhibition of 45Ca(2+) buffering in rat cerebellum by hydroxylated polychlorinated biphenyls.
    Kodavanti PR; Ward TR; Derr-Yellin EC; McKinney JD; Tilson HA
    Neurotoxicology; 2003 Mar; 24(2):187-98. PubMed ID: 12606291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diluted mainstream cigarette smoke condensates activate estrogen receptor and aryl hydrocarbon receptor-mediated gene transcription.
    Meek MD; Finch GL
    Environ Res; 1999 Jan; 80(1):9-17. PubMed ID: 9931222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.